inspection cycle (2016 to 2018), audit firms in the capital market established and maintained a system of quality control as required by the Thai Standard on Quality Control (“TSQC 1”). The majority of audit

from the first inspection cycle (2010-2012) to 2019, the first year of the 4th inspection cycle (2019-2021), showed promising overall improvement despite the SEC’s more intensive inspection in several

Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,454.77 617.92 Cost of selling medical equipment 125.25 122.84

Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,373.18 644.93 Cost of selling medical equipment 166.98 94.11

subsidiaries have the revenues from medical treatment of 947.83 million baht, which is a 7.48 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

subsidiaries have the revenues from medical treatment of 899.25 million baht, which is a 15.55 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

CRITERIA 5 OUR STARTING POINT 5 ENVIRONMENTAL IMPACTS OF SOLAR ASSETS 5 TREATMENT OF HYBRID SOLAR ENERGY ASSETS 7 LINKING SOLAR-SPECIFIC ASSETS IN THE MANUFACTURING SUPPLY CHAIN TO BONDS 7 PROPOSED

and its subsidiary for the fiscal year ended on December 31, 2018 as follows; Statements of Comprehensive Income Revenues from medical treatment The Company generated the revenues from medical treatment

subsidiaries have the revenues from medical treatment of 796.27 million baht, which is a 0.15 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

revenues from medical treatment of 3,621.15 million baht, which is a 6.42 % increase from the previous year. The revenues can from the three hospitals are broken down as follows : - Ramkhamhaeng Hospital